Proteasome Inhibition: A Novel Approach to Anticancer Therapy

By Paul G. Richardson   Teru Hideshima   Kenneth C. Anderson  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite

The Proteasome as a Target for Cancer Treatment: Focus on Bortezomib

By Papandreou Christos N.  

American Journal of Cancer, Vol. 4, Iss. 6, 2005-01 ,pp. : 359-372

Adis International

Access to resources Recommend Favorite

Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement

By Capalbo Silvana   Chiefa Antonia   Delia Mario   Diomede Daniela   Liso Vincenzo  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 262-264

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Mast Cell Activity as a New Approach to Anticancer Therapy

By Ionov I.D.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 287-291

Informa Healthcare

Access to resources Recommend Favorite

Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells

By    

Molecular Medicine Reports, Vol. 10, Iss. 5, 2014-01 ,pp. : 2609-2612

Spandidos Publications

Access to resources Recommend Favorite